Phebe Ekregbesi received a bachelor's degree in Biomedical Sciences from the University of Bath, before working as a research technician at Imperial College London. She completed a master's in Microbiology and Immunology from Johns Hopkins University, developing a new mouse model of placental malaria. In 2024, Phebe joined the Draper group as a project manager in the OptiViVax EU consortium project.